Asymptote is a Cambridge UK based company that specialises in the development and supply of cryo-chain equipment and consumables for use in regenerative medicine and other biological applications.
|Address:||St Johns Innovation Centre , Cowley Road, Cambridge|
|Membership type:||Corporate 6-20 (£250+VAT pa)|
Asymptote is a Cambridge UK based company that specialises in the development and supply of cryo-chain equipment and consumables for use in regenerative medicine and other biological applications. Its team comprises biologists, engineers, industrial designers and physicists all working together to enable the company to address the numerous challenges of successful cryopreservation. Asymptote is developing a suite of products to enable an end-to-end cryo-chain (freezing storage shipping and thawing) in a tightly controlled repeatable and regulatory compliant way. Asymptote has recently launched the VIA Freeze range of GMP compliant liquid nitrogen free controlled rate freezers and is also in the process of launching IceStart™ a biocompatible material which acts as an ice nucleant during the cooling of aqueous solutions.
Asymptote’s digitally-enabled cryogenic cold chain technology supports safe manufacture and delivery of cellular therapies
2 May 2017Read in full
GE Healthcare acquires Asymptote for complete, digitally-enabled cryogenic cold chain technology supporting safe manufacture and delivery of cellular therapies. The acquisition further strengthens GE Healthcare’s cell therapy portfolio with a suite of technologies for the cryopreservation of cellular materials
10 April 2017Read in full
Asymptote Ltd, specialists in cryochain technology for advanced medicines, has announced the commercial launch of my.Cryochain, a software platform developed specifically to give centralised control of the cryogenic cold chain for cellular therapies.
29 November 2016Read in full
Indianapolis, US, and Cambridge UK, 29th November 2016 Cook Regentec, focused on developing research and clinical tools to advance regenerative medicine therapies from the lab to the patient, and Asymptote Ltd., specialists in cryochain for regenerative medicine, today announced the launch of the CellSeal® Automated Thawing System.
29 November 2016Read in full
The Cell Therapy Catapult and Asymptote, a leading specialist in cryopreservation based in Cambridge, are combining forces to advance the development of a novel point-of-care Thawing System for Cell Based Therapies.
1 May 2015Read in full
Cambridge-based cryopreservation specialists Asymptote Ltd will launch its unique range of liquid nitrogen free controlled rate freezers specially designed for the needs of regenerative medicine at the annual meeting of the International Society for Cellular Therapy (ISCT) to be held in Paris.
23 April 2014Read in full
Cambridge-based cryopreservation specialists Asymptote Ltd, has been awarded a grant from the Technology Strategy Board to develop ways of improving the storage of live vaccines for use in the third world. Asymptote is developing ultra low temperature storage equipment which could help prevent vaccines from being discarded unnecessarily.
5 June 2013Read in full